Keymed Biosciences Inc. (2162.HK) has a MoatMap StockRank of 19/100 based on Quality (37/100), Value (38/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL. Keymed Biosciences, a Chinese healthcare company, does not exhibit a clear asymmetric macro tailwind from the provided themes to justify a high-conviction position.